FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283209539> ?p ?o ?g. }

• W4283209539 endingPage "205" @default.
• W4283209539 startingPage "194" @default.
• W4283209539 abstract "Inflammation plays an important role in diabetes mellitus (DM)-related acute ischemic stroke (AIS). The mechanisms of un-resolved inflammation in DM-related AIS are not fully understood. Specialized pro-resolving mediators (SPMs) are key regulators that promote resolution of inflammation. We aimed to examine resolution function in patients with AIS complicated with DM, and explore potential treatment effects of one of the SPMs, resolvin D2 (RvD2) ex vivo and in vivo.Cultured human macrophages, which were derived from peripheral blood mononuclear cells of AIS and none-AIS patients with or without DM, were stimulated with oxidized-low density lipoprotein (ox-LDL). Levels of SPMs and inflammatory markers were analysed, and RvD2 treatment effects were evaluated in these cells. For experiments in vivo, challenges with high fat diet and low-dose streptozotocin (STZ) were used to induce DM in C57BL/6J mice. AIS model was established by permanent middle cerebral artery occlusion (pMCAO) followed by intra-cerebroventricular injection of RvD2.Compared with macrophages of AIS patients without DM, the ratios of SPMs to leukotriene B4 (LTB4) were decreased in AIS patients with DM, accompanied by reduced expression of SPM synthesis enzyme, 15-lipoxygenase-1. Moreover, the levels of pro-inflammatory pathway markers were increased, and the macrophages were skewed to M1 polarization in AIS patients with DM. In mice, treatment with RvD2 ameliorated pMCAO-induced brain injury, neurological dysfunction, and inflammatory response. Furthermore, RvD2 rescued resolution of inflammation by promoting macrophage/microglia polarization to pro-resolving M2 phenotype ex vivo and in vivo.Our data demonstrate resolution of inflammation is impaired by DM in AIS patients, implicating a novel mechanism of un-resolved inflammation in DM-related AIS. Furthermore, RvD2 promotes inflammation resolution in macrophages/microglia and protects DM-related AIS, and may thus serve as a novel therapeutic target." @default.
• W4283209539 created "2022-06-22" @default.
• W4283209539 creator A5004838076 @default.
• W4283209539 creator A5004975090 @default.
• W4283209539 creator A5016144206 @default.
• W4283209539 creator A5030733041 @default.
• W4283209539 creator A5056222061 @default.
• W4283209539 creator A5058496930 @default.
• W4283209539 creator A5070892221 @default.
• W4283209539 creator A5081537753 @default.
• W4283209539 creator A5081646974 @default.
• W4283209539 creator A5091543149 @default.
• W4283209539 date "2022-08-01" @default.
• W4283209539 modified "2023-10-13" @default.
• W4283209539 title "Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment" @default.
• W4283209539 cites W1497700962 @default.
• W4283209539 cites W1989877233 @default.
• W4283209539 cites W1990770545 @default.
• W4283209539 cites W2007428607 @default.
• W4283209539 cites W2009190815 @default.
• W4283209539 cites W2054109306 @default.
• W4283209539 cites W2089162053 @default.
• W4283209539 cites W2090609282 @default.
• W4283209539 cites W2095444837 @default.
• W4283209539 cites W2120906589 @default.
• W4283209539 cites W2151295407 @default.
• W4283209539 cites W2151840463 @default.
• W4283209539 cites W2155099072 @default.
• W4283209539 cites W2157773926 @default.
• W4283209539 cites W2166102027 @default.
• W4283209539 cites W2210741139 @default.
• W4283209539 cites W2346184067 @default.
• W4283209539 cites W2510102221 @default.
• W4283209539 cites W2516378834 @default.
• W4283209539 cites W2523453502 @default.
• W4283209539 cites W2575475813 @default.
• W4283209539 cites W2588734186 @default.
• W4283209539 cites W2734893372 @default.
• W4283209539 cites W2775595726 @default.
• W4283209539 cites W2794117851 @default.
• W4283209539 cites W2886317149 @default.
• W4283209539 cites W2891725583 @default.
• W4283209539 cites W2894969135 @default.
• W4283209539 cites W2898599254 @default.
• W4283209539 cites W2900430109 @default.
• W4283209539 cites W2902253720 @default.
• W4283209539 cites W2902724713 @default.
• W4283209539 cites W2914637605 @default.
• W4283209539 cites W2916996193 @default.
• W4283209539 cites W2930124318 @default.
• W4283209539 cites W2948752107 @default.
• W4283209539 cites W2957360511 @default.
• W4283209539 cites W2972349431 @default.
• W4283209539 cites W2984785809 @default.
• W4283209539 cites W3025320509 @default.
• W4283209539 cites W3093037158 @default.
• W4283209539 cites W3093341913 @default.
• W4283209539 cites W3134973989 @default.
• W4283209539 cites W3136501705 @default.
• W4283209539 cites W3137595918 @default.
• W4283209539 doi "https://doi.org/10.1016/j.freeradbiomed.2022.06.231" @default.
• W4283209539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35750271" @default.
• W4283209539 hasPublicationYear "2022" @default.
• W4283209539 type Work @default.
• W4283209539 citedByCount "2" @default.
• W4283209539 countsByYear W42832095392023 @default.
• W4283209539 crossrefType "journal-article" @default.
• W4283209539 hasAuthorship W4283209539A5004838076 @default.
• W4283209539 hasAuthorship W4283209539A5004975090 @default.
• W4283209539 hasAuthorship W4283209539A5016144206 @default.
• W4283209539 hasAuthorship W4283209539A5030733041 @default.
• W4283209539 hasAuthorship W4283209539A5056222061 @default.
• W4283209539 hasAuthorship W4283209539A5058496930 @default.
• W4283209539 hasAuthorship W4283209539A5070892221 @default.
• W4283209539 hasAuthorship W4283209539A5081537753 @default.
• W4283209539 hasAuthorship W4283209539A5081646974 @default.
• W4283209539 hasAuthorship W4283209539A5091543149 @default.
• W4283209539 hasBestOaLocation W42832095391 @default.
• W4283209539 hasConcept C126322002 @default.
• W4283209539 hasConcept C127413603 @default.
• W4283209539 hasConcept C134018914 @default.
• W4283209539 hasConcept C150903083 @default.
• W4283209539 hasConcept C203014093 @default.
• W4283209539 hasConcept C207001950 @default.
• W4283209539 hasConcept C26291073 @default.
• W4283209539 hasConcept C2776685179 @default.
• W4283209539 hasConcept C2776914184 @default.
• W4283209539 hasConcept C2779830541 @default.
• W4283209539 hasConcept C2780645631 @default.
• W4283209539 hasConcept C555293320 @default.
• W4283209539 hasConcept C71924100 @default.
• W4283209539 hasConcept C78519656 @default.
• W4283209539 hasConcept C86803240 @default.
• W4283209539 hasConcept C98274493 @default.
• W4283209539 hasConceptScore W4283209539C126322002 @default.
• W4283209539 hasConceptScore W4283209539C127413603 @default.
• W4283209539 hasConceptScore W4283209539C134018914 @default.
• W4283209539 hasConceptScore W4283209539C150903083 @default.

• next